3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia, Myeloid, Acute
5
Myelodysplastic Syndromes
4
Burkitt Lymphoma
3
Blast Crisis
3
Anemia, Refractory, with Excess of Blasts
3
Primary Myelofibrosis
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Myeloproliferative Disorders
2
Multiple Myeloma
2
Lymphoma, T-Cell
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia
2
Hodgkin Disease
2
Congenital Abnormalities
2
Waldenstrom Macroglobulinemia
1
Thrombocythemia, Essential
1
Smoldering Multiple Myeloma
1
Sezary Syndrome
1
Recurrence
1
Precancerous Conditions
1
Polycythemia Vera
1
Plasmablastic Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neoplasms, Plasma Cell
1
Myelodysplastic-Myeloproliferative Diseases
1
Interventions
pembrolizumab
32
Cisplatin
23
Cetuximab
14
Carboplatin
13
Magnetic Resonance Spectroscopy
12
Specimen Handling
10
Radiotherapy, Intensity-Modulated
10
Paclitaxel
9
Nivolumab
9
Docetaxel
8
Platinum
7
1,2-diaminocyclohexaneplatinum II citrate
7
Radiotherapy
5
Biopsy
5
dostarlimab
4
atezolizumab
4
Immunoglobulin G
4
Fluorouracil
4
Disulfides
4
Bevacizumab
4
(225)Ac-DOTA-c(RGDyK)
4
cemiplimab
3
Taxes
3
Radiation
3
Fulvestrant
3
budigalimab
2
amivantamab
2
abemaciclib
2
Radiotherapy, Image-Guided
2
Pemetrexed
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Squamous Cell Carcinoma of Head and Neck
×
Peripheral Blood Stem Cell Transplantation
×
30 days
×
Clear all
No trials found.